After just two months of use the Japanese government has suspended their recommendation for inclusion of the HPV vaccine in the vaccination schedule. This abrupt change was triggered by unusually high amount of adverse events. The most common symptom was diffuse muscle pain but other symptoms included headache, muscle weakness, dizziness, joint pain, sleepiness and memory loss.
Laboratory tests found inflammatory cytokines in spinal fluid, reduced brain blood flow and high leukocyte sensitivity against aluminum. This should not be surprising since the HPV vaccine contains Amorphous Aluminum Hydroxyphosphate sulfate which has been implicated in numerous neurological and autoimmune disorders.
Despite tens of thousands of similar adverse effects occurring in the US population the FDA refuses to pull the vaccine.
Terry Pfau DO, HMD